Watch all 5 days here
With 10 incredibly current sessions, Wounds Week gives a chance for the wound care community to come together and engage in key education free of charge.

Each session will have a live Q&A so participants can ask questions of the experts and really feel part of the event.
This Series Has 5 Sections
  • Dr Grace Parfitt, Senior Lecturer in Podiatry, University of Huddersfield and James Linsley, High Risk Lead Podiatrist, NHS
    Monday: Larval debridement therapy: clinical considerations in chronic wounds
    Larval therapy is becoming increasingly more popular within the management of chronic wounds due to its supplementary therapeutic effects, including antimicrobial properties, alongside its primary mode of action of debridement. The session will explore the practical application of larval debridement therapy in chronic wounds. It will identify and discuss its advantages, barriers, and solutions in clinical practice.
    1631281636-ab5e0cea9c7680f3
  • Ojan Assadian, Medical Director of the Hospital Neunkirchen, Austria
    Tuesday: Clinical considerations for topical wound antisepsis or systemic antibiotic therapy
    The continuing increase of bacterial resistance against antibiotics has demanded to reserve their use for strict and few indications. Therefore, during the past 10 years, significant advances have been made in the field of wound antisepsis for the management of patients with chronic wounds.
    1608302592-79b9efcd3d3e2bc8
  • Prof. Karen Ousey, Prof. Barbara Conway, Dr. David Armstrong, Dr. Serge Bohbot, Prof. Michael Edmonds, and Dr. Marco Meloni
    Wednesday: Innovations in DFU management
    Innovations in DFU management 18:00 - 18:30 GMT

    Every 1.2 seconds, someone in the world with diabetes develops a limb-threatening foot wound. Every 20 seconds, someone with a wound undergoes an amputation. Three- and five-year mortality amongst people with amputation exceeds all but the most aggressive cancers. With these data as a backdrop, we will review the current state of play regarding treatment of the diabetic foot and wounds in the developed and developing world. We will explore policy factors associated with the team approach to amputation prevention as well as tips for the structure of successful teams, both at SALSA and worldwide.

    Innovation in diabetic foot care: How can R&D improve clinical outcomes ? 18:30 - 19:00 GMT

    Because diabetic foot ulcers are a source of suffering, our mission at Urgo Medical is to support healthcare professionals every day in healing their patients and making a difference by: Leading with science - Delivering innovative local treatments backed by robust clinical evidence thanks to continuous investment in R&D
    1608302602-335e29c45cb5cb58
  • Prof. Barbara Conway, University of Huddersfield, Prof. Karen Ousey, Institute of Skin Integrity and Infection Prevention and Dot Weir, Saratoga Hospital Medical Group Wound Healing
    Thursday: Innovations in diagnostics and wound management products
    This webinar is kindly sponsored by Molnlycke.

    The practice of wound management has evolved over the years enabling providers to further understand the barriers to healing and many consensus papers have been published providing guidance in the various aspects of caring for difficult to heal wounds. Technologies have been developed to aid in the early recognition of impediments to healing, overcome obstacles in care as well as improved accuracy in wound evaluation and documentation. Finally, innovations in materials to aid in wound cleansing and topical management have improved local care.
    1608302578-0320f99b1e2849eb
  • Prof. Amit Gefen, Tel Aviv University, Prof. Barbara Conway, University of Huddersfield, Prof. Karen Ousey, Institute of Skin Integrity and Infection Prevention and Sarah Gardner, WoundsMatter
    Friday: Innovations in lower limb management
    Holding back the tide: Why assessment is vital to exudate management of the lower limb 18:00 - 18:35 GMT

    Clinicians are often faced with patients presenting with lower limb conditions that are complicated by high levels of exudate. We often hear the term ‘wet legs’ being referred to and we know that leg ulceration can fail to heal when the wounds are chronic and peri-wound skin is damaged from unmanaged exudate. Unfortunately, the role of exudate is often misunderstood and therefore frequently overlooked as part of the assessment process. This can then lead to ineffective care and delayed healing. This session will explore the ‘science’ behind exudate, what you need to consider as part of your assessment process and discuss some of the solutions to effective exudate management of lower limb conditions.

    The desired performances of wound dressings for an effective exudate management 18:35 - 19:05 GMT

    A crucial aspect in effective wound care is exudate management. Excessive presence of exudate fluids typically involve wound exposure to elevated inflammatory cytokine levels and proteolytic enzymes. Pooling of exudate fluids also creates a medium for pathogen growth. Each and all of these factors may delay the healing. Peri-wound tissues may further be negatively affected by excess exudates, which wet newly regenerated tissues or periwound skin, resulting in tissue cross-contamination, additional inflammatory irritation or maceration of the periwound skin.
    1608302618-783259d3444ecb15
Email nurseledconferences@markallengroup.com to receive CPD after watching
Ead-messages-offsite-icon-1